PRESS RELEASE published on 09/16/2025 at 18:00, 10 months 21 days ago Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials Axiodis CRO, a subsidiary of Oxurion NV, leverages AI to enhance clinical trials with digital twins for disease simulation and AI modules integrated into Exagis eCRF solution for improved data quality and workflow efficiency AI Integration Clinical Trials Oxurion NV Digital Twins Axiodis CRO
PRESS RELEASE published on 09/16/2025 at 18:00, 10 months 21 days ago Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep, kondigt een dubbele strategische AI-initiatieven aan om klinische proeven te transformeren Axiodis CRO, een dochteronderneming van Oxurion, lanceert digitale tweelingen en integreert AI in eCRF-oplossing Exagis om klinische studies te versnellen en te beveiligen AI Axiodis CRO Exagis Digitale Tweelingen Klinische Studies
BRIEF published on 09/08/2025 at 18:05, 10 months 29 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Risques Financiers Atlas Special Opportunities Oxurion
BRIEF published on 09/08/2025 at 18:05, 10 months 29 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Financial Risks Oxurion
PRESS RELEASE published on 09/08/2025 at 18:00, 10 months 29 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC dat het aandelenbezit onder drempel van 10% is gezakt na verkoop van stemrechtverlenende effecten Transparantiekennisgeving Oxurion NV Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
PRESS RELEASE published on 09/08/2025 at 18:00, 10 months 29 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding change in shareholding. Oxurion specializes in acquiring majority stakes in European pharmaceutical subcontractors Transparency Notification Shareholding Change Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF published on 09/01/2025 at 18:05, 11 months 6 days ago Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Seuils De Participation
BRIEF published on 09/01/2025 at 18:05, 11 months 6 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Participation Thresholds
PRESS RELEASE published on 09/01/2025 at 18:00, 11 months 6 days ago Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aankoop en verkoop van aandelen, voldoet aan Belgische transparantiewetgeving Transparantiekennisgevingen Aandelen Oxurion Belgische Wetgeving Atlas Special Opportunities II LLC
PRESS RELEASE published on 09/01/2025 at 18:00, 11 months 6 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications under Belgian legislation from Atlas Special Opportunities II, LLC regarding changes in voting securities holdings Oxurion NV Belgian Legislation Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
Published on 08/07/2026 at 23:15, 2 hours 6 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 hours 21 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 hours 51 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 3 hours 6 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 2 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 5 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 6 hours 6 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 7 hours 11 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 7 hours 21 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 6 hours 27 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 6 hours 27 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 6 hours 41 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 6 hours 41 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 7 hours 21 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026